MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Deep brain stimulation matters in pediatric neurology – single-center experience

M. Freilinger, A. Zeitlberger, S. Siegert, R. Seidl, F. Alesch, G. Kranz, K. Novak (Vienna, Austria)

Meeting: 2018 International Congress

Abstract Number: 446

Keywords: Deep brain stimulation (DBS), Dyskinetic cerebral palsy syndrome, Dystonia: Treatment

Session Information

Date: Saturday, October 6, 2018

Session Title: Pediatric Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: This study is to review our single-center experience with deep brain stimulation (DBS) in pediatric patients with dystonia.

Background: Deep brain stimulation (DBS) is an established therapy option for movement disorders. Knowledge about the indication and efficacy in children with heterogeneous genetic and acquired dystonia is limited.

Methods: Single-center data from all pediatric patients treated with DBS before the age 18 was assessed retro- and prospectively. Etiology, surgical and stimulation parameters as well as side effects were documented. Outcome was assessed using function specific scores, quality of life questionnaires, established movement disorder rating scales and self-rating.

Results: Since 2008, 8 children (mean age at surgery 13.1 years, range 7-17 years) underwent DBS implantation at the Medical University Hospital Vienna. Two patients were diagnosed with genetic dystonia (TOR1A, KMT2B), one with Lesch-Nyhan disease, and five with acquired dystonia. All patients underwent bilateral stereotactic surgery (globus pallidus internus) under general anesthesia. Electrode revision due to displacement and intermittent hardware removal after infection was necessary in one patient each. Observation periods range from 1 to 10 years. Results of standardized assessments revealed the greatest improvements in patients with genetic dystonia but heterogeneous outcomes in acquired dystonia.

Conclusions: Our single-center experience adds to the growing evidence that DBS is a safe therapy option in pediatric patients. Patients with both well-described (TOR1A) and only recently discovered underlying genetic mutations (KMT2B) demonstrate remarkable improvements after DBS. However, within the more prevalent group of children with acquired dystonia, robust prognostic factors are still lacking. Established dystonia rating scales designed for adults do not reflect parental subjective assessment of functional outcome.

To cite this abstract in AMA style:

M. Freilinger, A. Zeitlberger, S. Siegert, R. Seidl, F. Alesch, G. Kranz, K. Novak. Deep brain stimulation matters in pediatric neurology – single-center experience [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/deep-brain-stimulation-matters-in-pediatric-neurology-single-center-experience/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/deep-brain-stimulation-matters-in-pediatric-neurology-single-center-experience/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley